Understanding Multiple Endocrine Neoplasia Type 1

publication Evidence: moderate

Author Information

Author(s): Marini Francesca, Falchetti Alberto, Monte Francesca Del, Sala Silvia Carbonell, Gozzini Alessia, Luzi Ettore, Brandi Maria Luisa

Primary Institution: University of Florence, Florence, Italy

What are the clinical and genetic features of Multiple Endocrine Neoplasia type 1 (MEN1)?

Early recognition and genetic testing for MEN1 can significantly reduce morbidity and mortality associated with the syndrome.

MEN1 occurs in approximately one in 30,000 individuals.
More than 95% of MEN1 patients develop clinical manifestations by the fifth decade.
Total parathyroidectomy is the proposed effective treatment for symptomatic hypercalcaemic MEN1 patients.

MEN1 is a rare genetic condition that can cause tumors in different glands, and finding it early helps people get the right treatment.

The study reviews clinical and genetic features of MEN1, including its diagnosis and management.

The variability in clinical manifestations makes it difficult to predict outcomes for individuals with MEN1.

MEN1 affects individuals across all age groups, with symptoms often beginning in the fourth or fifth decade of life.

Access the complete publication on the publisher's website